Our mission is opening a digital front door to a new kind of healthcare system, one that provides greater access to high quality, convenient and affordable care. No matter who a person is, where they come from, what they look like, or if they have insurance or not—Hims & Hers connects consumers with licensed medical professionals and enables everyone to seek health and wellness care.

HIMS

Andrew Dudum

Chief Executive Officer

Melissa Baird

Chief Operating Officer

Soleil Boughton

Chief Legal Officer and Corporate Secretary

Yemi Okupe

Chief Financial Officer

Chief Executive Officer And Board Of Director

Alex Bard

Board Of Director

Dr. Toby Cosgrove

M.D. Board Of Director

Kirsten Green

Jules Maltz

David Wells

Lynne Chou O’keefe

Andrea Perez

Ambar Bhattacharyya

Dr. Patrick Carroll

About HIMS

옵션 체인은 다양한 행사가격과 만기일에 대한 Hims & Hers Health의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Hims & Hers Health에 대한 시장 심리를 평가합니다..

Hims & Hers Health (NYSE:HIMS) 주식, 옵션 체인

Hims & Hers Health

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Hims & Hers Health, Inc. Class A Common Stock

NXPI

PLTR

TSLA

월요일(4일) 미국 증시는 S&amp;P 500 지수가 약 0.3% 하락하는 등 소폭의 하락세를 보였다. 다우존스 지수는 0.6% 하락한 41,794.60포인트를 기록했고, 나스닥 종합지수는 0.3% 하락한 18,179.98포인트를 기록했다.이날 미국 주식 시장에서 개인 트레이더와 투자자들이 가장 주목한 종목은 다음과 같다.

월요일 주목받은 주식: 팔란티어, 트럼프 미디어, 힘스 앤 허스, NXP 세미컨덕터 및 테슬라

Earnings

News

Guidance

Health Care

After-Hours Center

Movers

힘스 앤 허스 헬스(NYSE: HIMS)가 월요일 시장 마감 후 3분기 실적을 발표했다. 이 발표로 주가는 시간외 거래에서 7% 이상 상승했다. 보고서의 세부 사항은 다음과 같다.

힘스 앤 허스 헬스의 주식은 강력한 3분기 실적과 연간 전망 상향 발표로 7% 이상 상승

힘스 앤 허스 헬스(NYSE:HIMS)는 월요일 2분기 재무 결과를 발표했다. 보고서의 세부 정보는 다음과 같다. 주요 정보: 힘스 앤 허스 헬스는 분석가 합의 추정치인 3센트를 웃도는 주당 6센트의 분기 이익을 보고했다.

힘스 앤 허스는 예상보다 우수한 2분기 매출과 이익을 발표

Hims & Hers Health Inc

Wells Fargo analyst Elyse Greenspan maintains Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with a Equal-Weight and raises the price target from $116 to $117.

Price Target

Analyst Ratings

Wells Fargo Maintains Equal-Weight on Prudential Financial, Raises Price Target to $117

Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) has outperformed the market over the past 10 years by 6.32% on an annualized basis producing an average annual return of 17.2%. Currently, Novo Nordisk has a market capitalization of $482.39 billion. 
Buying $1000 In NVO: If an investor had bought $1000 of NVO stock 10 years ago, it would be worth $5,007.62 today based on a price of $110.14 for NVO at the time of writing.
<h3>Novo Nordisk's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730820641_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today

Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) has outperformed the market over the past 10 years by 1.96% on an annualized basis producing an average annual return of 12.85%. Currently, Agilent Technologies has a market capitalization of $39.86 billion. 
Buying $100 In A: If an investor had bought $100 of A stock 10 years ago, it would be worth $335.90 today based on a price of $138.74 for A at the time of writing.
<h3>Agilent Technologies's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730820637_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today

Emerson Electric Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) shares traded higher on Tuesday after the company reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41740106/emerson-reports-fourth-quarter-and-full-year-2024-results-provides-initial-2025-outlook" rel="noreferrer noopener">fourth-quarter&nbsp;FY24 results</a>.
Net sales growth of 13% year over year to $4.62 billion, beating the consensus of $4.57 billion. Underlying sales were up 4%, and underlying orders increased by 2% in the quarter. Adjusted EPS improved 15% to $1.48, <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">beating the consensus of $1.47</a>.
Sales by Segments: Final Control&nbsp;$1.17 billion&nbsp;(+8%), Measurement &amp; Analytical&nbsp;$1.12 billion&nbsp;(+7%), Discrete Automation&nbsp;$643 million&nbsp;(-3%); Safety &amp; Productivity&nbsp;$352 million&nbsp;(-1%), Control Systems &amp; Software&nbsp;$780 million&nbsp;(+9%), AspenTech&nbsp;$215 million&nbsp;(-13%), and Test &amp; Measurement&nbsp;$360 million.
Adjusted Total Segment EBITA was&nbsp;$1.21 billion&nbsp;compared to&nbsp;$1.05 billion&nbsp;in the prior&nbsp;year&nbsp;quarter, and the margin improved by 70&nbsp;bps to&nbsp;26.2%.
Emerson&#8217;s operating cash flow for the quarter totaled $1.07 billion, compared to $991 million in the prior year, and free cash flow was $905 million (+10% Y/Y). Emerson held cash and equivalents of $8.05 billion as of September-end.
Dividend: Emerson declared a quarterly cash dividend per share of $0.5275 (vs. $0.525 prior quarter), payable on December 10, to stockholders of record on&nbsp;November&nbsp;15, 2024.
Emerson President&nbsp;and Chief Executive Officer&nbsp;Lal Karsanbhai&nbsp;said, &#8220;We have done an exceptional job integrating Test &amp; Measurement with&nbsp;$100 million&nbsp;of synergies realized in the first year, and we remain resolute in our focus on executing at a world-class level, guided by our Emerson Management System. Emerson&#8217;s leading technology, alignment with secular trends and customer focus provide confidence for continued momentum in fiscal 2025.&#8221;
Outlook: For FY25, Emerson Electric expects its net sales growth outlook of 3.5% &#8211; 5.5%, with underlying sales growth of 3% &#8211; 5% and adjusted EPS of $5.85 &#8211;<a href="https://www.benzinga.com/calendars/guidance" target="_blank" rel="noreferrer noopener"> $6.05 vs. consensus $5.48</a>.
Emerson expects an operating cash flow of&nbsp;$3.6 billion &#8211; $3.7 billion&nbsp;and an FCF of&nbsp;$3.2 billion &#8211; $3.3 billion&nbsp;for FY25.
For the first quarter, the company projects net sales growth of 2.5% &#8211; 3.5% and adjusted EPS of $1.25&nbsp;&#8211;&nbsp;$1.30&nbsp;vs. consensus of $1.28.
Emerson disclosed plans to boost capital returns to shareholders with a share repurchase program totaling around $2 billion for FY25, including $1 billion expected in the fiscal first quarter.
Acquisition: In a separate release, Emerson proposed acquiring all remaining shares of Aspen Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>) for an <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n41740121/emerson-announces-key-actions-to-complete-the-portfolio-transformation-to-an-industrial-technology" rel="noreferrer noopener">enterprise value of&nbsp;$15.1 billion</a>.
Emerson&#8217;s proposal of $240 per share offers a 35% premium over AspenTech&#8217;s undisturbed share price of $177.84 on August 6, and an 8% premium above its 52-week high of $221.94 through&nbsp;August 6.
Emerson currently owns approximately&nbsp;57%&nbsp;of AspenTech&#8217;s outstanding shares of common stock. Upon completing the transaction, AspenTech would become Emerson&#8217;s wholly-owned subsidiary.
Emerson anticipates that the proposed transaction, including synergies, will have a neutral effect on its Adjusted EPS in fiscal 2025.
Emerson has also initiated a strategic review of its Safety &amp; Productivity segment, considering options like a cash sale. This segment includes the remaining non-automation businesses in Emerson&#8217;s portfolio.
Investors can gain exposure to the stock via&nbsp;ProShares S&amp;P Kensho Smart Factories ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAKX#NYSE">MAKX</a>) and&nbsp;Gabelli Automation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAST#NYSE">GAST</a>).
Price Action: EMR shares are up 8.6% at $119.25 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/41745824" target="_blank" rel="noreferrer noopener">Short Squeeze &#8211; GlobalFoundries Stock Soars On Q3 Earnings Beat, Strong Q4 Outlook</a></li>
</ul>

Equities

Large Cap

Dividends

Buybacks

Asset Sales

AZPN

GAST

MAKX

Emerson Electric Gains On Q4 Earnings Beat And FY25 Growth Forecast: Eyes AspenTech Buyout

Pineapple Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NYSE">PEGY</a>) short percent of float has risen 2843.09% since its last report. The company recently reported that it has 281 thousand shares sold short, which is 91.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Pineapple Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730820622_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Pineapple Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Pineapple Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Pineapple Energy's peer group average for short interest as a percentage of float is 3.98%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

PEGY

(PEGY) - Analyzing Pineapple Energy's Short Interest

JD.com's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JD#NYSE">JD</a>) short percent of float has fallen 11.24% since its last report. The company recently reported that it has 38.34 million shares sold short, which is 3.16% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.3 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>JD.com Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730820617_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for JD.com has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing JD.com's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, JD.com's peer group average for short interest as a percentage of float is 9.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into JD.com's Recent Short Interest

Sunrun's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RUN#NYSE">RUN</a>) short percent of float has risen 3.38% since its last report. The company recently reported that it has 46.62 million shares sold short, which is 25.09% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.56 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sunrun Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730820612_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sunrun has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Sunrun's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sunrun's peer group average for short interest as a percentage of float is 9.22%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Sunrun?

Truist Securities analyst Joon Lee maintains Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) with a Buy and lowers the price target from $12 to $8.

EDIT

Truist Securities Maintains Buy on Editas Medicine, Lowers Price Target to $8

Wells Fargo analyst Elyse Greenspan maintains MetLife (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) with a Overweight and raises the price target from $92 to $93.

Wells Fargo Maintains Overweight on MetLife, Raises Price Target to $93

Truist Securities analyst Michael Ciarmoli maintains BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) with a Hold and raises the price target from $95 to $106.

BWXT

Truist Securities Maintains Hold on BWX Technologies, Raises Price Target to $106

Wells Fargo analyst Elyse Greenspan maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Equal-Weight and raises the price target from $106 to $107.

Wells Fargo Maintains Equal-Weight on Aflac, Raises Price Target to $107

Truist Securities analyst Michael Ciarmoli maintains Air Transport Services Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATSG#NASDAQ">ATSG</a>) with a Hold and raises the price target from $15 to $22.5.

ATSG

Truist Securities Maintains Hold on Air Transport Services Gr, Raises Price Target to $22.5

Wells Fargo analyst Michael Sison maintains LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) with a Overweight and lowers the price target from $110 to $105.

Wells Fargo Maintains Overweight on LyondellBasell Industries, Lowers Price Target to $105

WIIM

INTC

Intel shares are trading higher following a report suggesting CEO Pat Gelsinger met with TSMC Chairman C.C. Wei to finalize 2nm and 3nm production capacity for 2024 and 2025.

Good Morning Traders! In today&#39;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#39;s pulse to optimize your trading gains. Now, let&#39;s dive into the stock analysis:
<h3>SPDR S&amp;P 500 ETF Trust </h3>
SPY&nbsp;(ARCA: SPY) is currently holding near our focal level of 571.06. For bullish momentum, we&#39;d like to see an early advance to 572.15. If price action shows resilience above 572.15, we&rsquo;re expecting buyers to extend the price to the support area of 573.50. A steady hold above 573.60 during regular trading hours could set up a move to the next target at 574.65, with our high bull target for the session at 575.67.
On the downside, failure to sustain above 571.06 may invite bearish pressure. In that scenario, we&#39;re watching for a test at 569.98. Persistent selling could see bears challenge lower support at 569.16, and a deeper breakdown could drive SPY down to a firm support at 567.81. In a high-volatility session, our low bear target for SPY is positioned at 566.46.
<h3>Invesco QQQ Trust Series 1</h3>
The QQQ (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>) is currently navigating around our level of 487.69. For bullish action, buyers should defend this level and aim to push up towards 490.05. A confirmed hold above 490.05 could bring 491.82 into play, showing renewed buyer confidence. If momentum holds, we&rsquo;re looking for a potential move higher to 493.60, with our optimistic bull target set at 495.35 for the day.
If QQQ struggles to hold above 487.69 in today&rsquo;s session, it may present an opportunity for bears to step in. A move lower could challenge 486.10, and persistent weakness could see further downside to 483.95. If sellers remain active, a test of 481.73 is likely. Should selling intensify, the low bear target for QQQ today sits at 479.03.
<h3>Apple Inc.</h3>
Apple&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) is currently trading around our identified level of 221.66. Bulls will be looking for 222.24 to provide a base for a push higher. Should the auction hold above 222.24, the next upward target is 222.96, signaling bullish continuation. If buying momentum remains, we anticipate a test of 223.87, with the high bull target for Apple placed at 225.31.
If Apple fails to maintain support at 221.66, we could see a bearish test lower toward 220.97. Continued selling might drive the price down to 220.29, with bears pushing further if downward pressure persists. A breakdown here could lead Apple toward 219.19, and if this level fails, our low bear target for the day is at 218.08.
<h3>Microsoft Corp. </h3>
Microsoft&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/msft#NASDAQ">MSFT</a>) is currently situated near our key level of 409.69. Bulls will look to defend this area and drive prices up toward 410.64. If this level solidifies as support, we may see a continuation rally toward 411.72. Consistent buyer strength today could lead Microsoft to its high bull target of 413.14.
A failure to hold 409.69 as support could open the door for a bearish test at 408.46. If bearish sentiment dominates, 407.11 may come into play as the next lower support. Continued selling pressure could lead Microsoft down to 406.01, with the day&rsquo;s low bear target set at 404.92 if sellers maintain control.
<h3>NVIDIA Corporation </h3>
NVIDIA&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) is auctioning near our level of 136.98. For a bullish session, we want to see the price advance to 137.94, holding this level as a base for upward movement. If buyers maintain this level, we may see a rally toward 138.55. Sustained buying could lift NVIDIA to our high bull target of 140.28.
If NVIDIA breaks below 136.98, bearish momentum could bring it down to test support at 135.64. Persistent selling might push the auction lower to 134.56. Should the downtrend continue, a test at 133.31 is expected, with the low bear target of 132.19 if the session weakens further.
<h3>Alphabet Inc Class A</h3>
Alphabet (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) is currently near our level of 169.34. Bulls aim to uphold this level, pushing the price toward 171.14. If the auction stabilizes above 171.14, we may see a potential test of our high bull target at 172.28.
If 169.34 breaks down as support, bears may attempt to drive prices lower to 167.04. Sustained selling could press GOOGL down to 165.41, and if selling intensifies, the low bear target for the day is positioned at 163.79.
<h3>Meta Platforms Inc </h3>
Meta&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meta#NASDAQ">META</a>) is currently balancing around 565.53. Bulls will want to see this level held firmly, allowing the price to rise toward 573.25. If buyers maintain their strength, we could see an extension to 580.17, aiming for the high bull target at 585.73.
If Meta fails to keep support at 565.53, bearish movement could drive the price down to 559.29. Further selling pressure might bring 553.05 into play, and if the downside trend continues, the low bear target for Meta is set at 548.44.
<h3>Tesla Inc. </h3>
Tesla&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) is auctioning near our level of 248.37. Bulls will look to push higher to 250.25 and sustain the buying momentum above this level. If strong demand persists, we could see Tesla testing 252.38, with further upside bringing the high bull target at 256.34 into play.
If Tesla fails to hold 248.37 as a base, bears might seize control and drive prices toward 246.16. A break below this level could lead to a test at 243.98, with the low bear target set at 242.49 if selling pressure mounts.
Final Word: Today&#39;s trading session brings minimal economic data but some noteworthy events that could impact the markets. At 8:30 AM ET, the Trade Balance for September is set for release, offering insight into the country&rsquo;s export-import landscape. At 10 AM ET, the ISM Services Index for October will be published, providing a read on the strength of the service sector. Later, at 1 PM ET, the Treasury will conduct a 10-Year Note Auction, which could influence bond yields and overall market sentiment. Adding to the day&rsquo;s complexity, the U.S. Presidential Elections are taking place, and the outcomes could introduce unexpected volatility. This combination of factors calls for a cautious approach. Be prepared for quick market shifts, manage risk attentively, and trade safely amidst what may be a particularly unpredictable session. Best of luck in today&rsquo;s trade!
The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.
Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day&mdash;hours before it&#39;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Markets

General

AAPL

GOOGL

MSFT

NVDA

Market Clubhouse Morning Memo - November 5th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)

Wells Fargo analyst Elyse Greenspan maintains Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) with a Equal-Weight and raises the price target from $175 to $186.

Wells Fargo Maintains Equal-Weight on Allstate, Raises Price Target to $186

VRTX

Vertex Pharmaceuticals shares are trading higher after the company reported better-than-expected Q3 financial results and issued FY24 product revenue guidance above estimates. Also, Morgan Stanley maintained an Equal-Weight rating on the stock and raised its price target from $473 to $476.

Wells Fargo analyst Yanan Zhu maintains Editas Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDIT#NASDAQ">EDIT</a>) with a Overweight and lowers the price target from $9 to $7.

Wells Fargo Maintains Overweight on Editas Medicine, Lowers Price Target to $7

<a href="https://darkwebinformer.com/engineer-is-allegedly-selling-partner-portal-access-to-rapid7s-open-data/">https://darkwebinformer.com/engineer-is-allegedly-selling-partner-portal-access-to-rapid7s-open-data/</a>
&nbsp;
&#x1F517; DarkWebInformer.com - Cyber Threat Intelligence &#x1F4C5; Date: 2024-11-05 02:27:28 &#x1F6A8; Title: Alleged sale of partner portal access to Rapid7's Open Data &#x1F6E1;&#xFE0F; Victim Country: USA
&#x1F3ED; Victim Industry: Computer &amp; Network Security &#x1F3E2; Victim Organization: rapid7 &#x1F310; Victim Site: opendata.rapid7.com &#x1F4DC; Category: Data Breach &#x1F517; Claim: <a href="https://breachforums.st/Thread-PARTNER-PORTAL-ACCESS-TO-OPEN-DATA-RAPID7">https://breachforums.st/Thread-PARTNER-PORTAL-ACCESS-TO-OPEN-DATA-RAPID7</a> &#x1F575;&#xFE0F;&#x200D;&#x2642;&#xFE0F; Threat Actor: engineer &#x1F30D; Network: openweb &#x1F4DD; Description: The threat actor claims to be selling partner portal access to Rapid7's Open Data, which offers extensive data from Project Sonar's internet-wide surveys. Project Sonar collects global telemetry to identify common vulnerabilities, providing researchers with data to support public security projects. The alleged access includes 84.8 TB of data across 71,125 files, potentially enabling security insights for research, government security advocacy, and commercial security projects.

Rumors

Watching Rapid7; Traders Circulate Dark Web Informer Post Saying "Engineer Is Allegedly Selling Partner Portal Access To Rapid7's Open Data"

Wells Fargo analyst Elyse Greenspan maintains Everest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>) with a Equal-Weight and lowers the price target from $406 to $402.

Wells Fargo Maintains Equal-Weight on Everest Group, Lowers Price Target to $402

Says trajectory in 2024 "nothing short of phenomenal." Says business trajectory setting "robust foundation" for 2025. Comments taken from Q3 earnin...

Hims & Hers to stop reporting on orders, average order value after 2024

Check out this evening's top movers from around Wall Street, compiled by The Fly.&nbsp;&nbsp; HIGHER AFTER EARNINGS – QuinStreet&nbsp;(QNST)&nbsp;u...

Closing Bell Movers: Palantir jumps 13% after results

Hims & Hers Health, Inc. (HIMS) Q3 2024 Earnings Call Transcript

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), Avanos Medical (AVNS...

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Avanos Medical (AVNS) and Alphatec Holdings (ATEC)

Hims & Hers: A Lot More Than Just GLP-1, And It's Proving Its Ability To Grow

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q3 earnings. Here is a breakdown of the information Hims & Hers Health, Inc. presented to its...

Hims & Hers Health Reports Strong Q3 2024 Growth

Biggest stock movers Tuesday: CLF, PLTR, and more

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a pr...

Piper Sandler Remains a Hold on Hims & Hers Health (HIMS)

Hims & Hers to launch a generic for Novo's older GLP-1

Seaport Global analyst Aaron Kessler maintained a Buy rating on Hims & Hers Health (HIMS – Research Report) today and set a price target of $32.00....

Seaport Global Sticks to Their Buy Rating for Hims & Hers Health (HIMS)

ALAB

ATEC

ATUS

AVNS

BOOM

BOWL

CRUS

DLTR

EVER

FANG

FWRD

GKOS

HDSN

HOLX

ILMN

LSCC

NONOF

QNST

SLAB

VMEO

WYNN

Screenshot 2024-09-04 at 5.36.44 PM

Biotech

MGRX

Prescribing The Future: How MangoRx Is Shaking Up Telemedicine With A Fresh Platform

Screenshot 2024-07-09 at 1.59.17 PM

Erectile Function Vs Erectile Dysfunction: How MangoRx&#39;s (NASDAQ: MGRX) Product Sets Itself Apart And Caters To A Large Market (Pun Intended)

Emerging Telemedicine Leaders: Stocks Shaping Healthcare's Digital Future

Press Releases

Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results

Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders

Hims & Hers Health Set to Join S&P SmallCap 600

Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024

Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers

Define Ventures Appoints Bruce Broussard as Venture Partner

How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals

Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results

GDRX

SPGI

TDOC

Addus HomeCare Corporation - Common Stock

Addus HomeCare

Agilon Health

Amedisys

AMN Healthcare Services

Astrana Health

BrightSpring Health Services, Inc. - Common Stock

BrightSpring Health

Chemed

Cigna

CorVel

CVS Health

Quest Diagnostics Incorporated Common Stock

Quest Diagnostics

DaVita

Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)

Comments

Hims & Hers Health

Hims & Hers Health (HIMS) 옵션

Hims & Hers Health (NYSE:HIMS) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌